Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor

被引:47
|
作者
Soulet, C
Sauzeau, V
Plantavid, M
Herbert, JM
Pacaud, P
Payrastre, B
Savi, P
机构
[1] Sanofi Synthelabo Rech, CVT Res Dept, F-31036 Toulouse, France
[2] Fac Sci Nantes, INSERM, U533, Nantes, France
[3] Hop Purpan, Dept Oncogenese & Signalizat Cellules Hematopoiet, CPTP, INSERM,U563, Toulouse, France
关键词
ADP; Gi-dependent and -independent pathways; P2Y(12); signal transduction;
D O I
10.1111/j.1538-7836.2004.00556.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The P2Y(12) ADP receptor is one of the major regulators of platelet activation and the target of antithrombotic thienopyridines (ticlopidine and clopidogrel). It has been recently cloned but the signaling pathways triggered by this receptor are still poorly documented. Here, we show that stimulation of the human P2Y(12) receptor stably expressed in Chinese hamster ovary cells activates two major intracellular signaling mechanisms leading either to cell proliferation or to actin cytoskeleton reorganization. Both effects were blocked by the active metabolite of clopidogrel, a specific antagonist of P2Y(12). The P2Y(12)-mediated stimulation of proliferation required the pertussis toxin-sensitive activation of PI3-kinase/Akt upstream of MAP-kinases. A partial contribution of a transactivation mechanism, through the tyrosine kinase receptor platelet-derived growth factor (PDGF)-R-beta, was also observed. Conversely, the P2Y(12)-mediated reorganization of the actin cytoskeleton was Gi-independent, requiring activation of RhoA and Rho-kinase. Our results provide new insights into the molecular basis of P2Y(12)-mediated intracellular signaling. These data may prove to be useful for a better understanding of the physiological role of P2Y(12), particularly in platelets and glial cells which express this important therapeutic target.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 50 条
  • [41] Effect of immature platelets on ADP-induced platelet reactivity after infusion of the P2Y12 receptor inhibitor cangrelor and transitioning to oral P2Y12 inhibitors
    Stratz, C.
    Nuhrenberg, T.
    Kleiner, P.
    Leggewie, S.
    Neumann, F. J.
    Hochholzer, W.
    Trenk, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S23 - S23
  • [42] Monitoring platelet inhibition induced by P2Y12 receptor blockade:: A comparison of P2Y12 specific assays
    Angiolillo, Domiaick J.
    Desai, Bhaloo
    Hang, Yuan
    Charlton, Ronald
    Bernardo, Esther
    Shoemaker, Steven
    Zenni, Martin
    Guzman, Luis
    Gilmore, Paul
    Bass, Theodore A.
    Costa, Marco A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 205M - 206M
  • [43] Activation of microglia by extracellular ATP through GI/O-coupled P2Y12 receptor
    Kohsaka, S
    Ohsawa, K
    Sasaki, Y
    Honda, S
    Imai, Y
    Inoue, K
    JOURNAL OF NEUROCHEMISTRY, 2004, 88 : 11 - 11
  • [44] The P2Y12 receptor: no active metabolite, no party
    Carlo Patrono
    Nature Reviews Cardiology, 2009, 6 : 271 - 272
  • [45] The P2Y12 receptor as a target of antithrombotic drugs
    O'Connor, Stephen
    Montalescot, Gilles
    Collet, Jean-Philippe
    PURINERGIC SIGNALLING, 2011, 7 (03) : 325 - 332
  • [46] The Function and Regulation of Platelet P2Y12 Receptor
    Li, Xiaohua
    Zhang, Guoxing
    Cao, Xia
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (01) : 199 - 216
  • [47] P2Y12 RECEPTOR AS A THERAPEUTIC TARGET IN SEPSIS
    Liverani, E.
    Rico, M. C.
    Kunapuli, S. P.
    Kilpatrick, L.
    SHOCK, 2015, 43 (06): : 82 - 83
  • [48] Biology and pharmacology of the platelet P2Y12 receptor
    Storey, Robert F.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (10) : 1255 - 1259
  • [49] The P2Y12 receptor: no active metabolite, no party
    Patrono, Carlo
    NATURE REVIEWS CARDIOLOGY, 2009, 6 (04) : 271 - 272
  • [50] The Function and Regulation of Platelet P2Y12 Receptor
    Xiaohua Li
    Guoxing Zhang
    Xia Cao
    Cardiovascular Drugs and Therapy, 2023, 37 : 199 - 216